Biogen Inc. - Company & Market Research Reports

Home /
Companies /
Biogen Inc.

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

REFINE BY

KEYWORD

CATEGORIES

Central Nervous System Drugs 155
Immune Disorders Drugs 73
Genomics 73
Biopharmaceuticals 73
Biotechnology 50
Pharmaceuticals 43
Musculoskeletal Disorders Drugs 42
Oncology Drugs 41
Drug Discovery 39
Hematological Drugs 36
Biosimilars and Biosuperiors 31
Alzheimer's Disease Drugs 27
Infusions and Injectables 25
Cardiovascular Drugs 24
Allergy and Immunology 22
Clinical Trials 22
Optical Disorders Drugs 21
Mental Disorders Drugs 19
Neurology 17
Needles and Syringes 17
E-Healthcare 14
Respiratory Drugs 14
Psoriasis Drugs 14
Infectious Diseases Drugs 12
Optical 12
Pharmaceutical Manufacturing 12
Immunosuppressive Drugs 12
Healthcare Services 11
Hematology 11
Gastrointestinal Drugs 11
Drug Delivery 10
Drugs by Therapeutic Area 9
Lymphoma Drugs 9
Diagnostics 9
Endocrine and Metabolic Disorders Drugs 9
Therapeutic Area 8
Leukemia Drugs 8
Analgesics 8
Pulmonary Medicine 7
Liver and Kidney Disorders Drugs 7
Enzymes 5
Medical Devices 5
Oncology 5
Schizophrenia Drugs 5
Company Reports 4
Proteomics 4
Mental Health 4
Neurology Devices 4
Cardiology 4
Pharmaceutical Intermediates 3
Generic Drugs 3
Stem Cells 3
Hospital Management 3
Dermatology 3
Vitamins and Dietary Supplements 3
Gastroenterology 3
Dermatological Drugs 3
Urology and Nephrology 2
Pharmacoeconomics 2
Prostate Cancer Drugs 2
In Vitro Diagnostics 2
Managed Care 2
Diabetes Devices 2
Biomaterials 2
Biomarkers 2
Vaccines 2
Skin Cancer Drugs 2
Laboratory Equipment 2
Pediatrics 2
Anxiety Drugs 2
Addiction Disorders Drugs 1
Diabetes Drugs 1
Women's Health 1
Fertility Services 1
Lung Cancer Drugs 1
Colon Cancer Drugs 1
Cervical Cancer Drugs 1
Brain Cancer Drugs 1
Medical Imaging 1
Infectious Disease Testing 1
Transdermal and Transmucosal Drug Delivery 1
Contrast Media 1
Kidney Cancer Drugs 1
Nanomedicine 1
Antibiotics 1
Clinical Skills 1
Anatomy 1
Endocrinology 1
Allergy Drugs 1
Asthma Drugs 1
Sexual and Reproductive Health Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

860 Results (Page 35 of 43)
- Relevance
  Sort by

Personalized Medicine Market Report 2025

 Report
September 2025
250 Pages
Global

From

€4029EUR$4,490USD£3,536GBP

DNA Repair Drugs Market Report 2025

 Report
September 2025
250 Pages
Global

From

€4029EUR$4,490USD£3,536GBP

Pharmaceutical PEG Derivative Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
February 2024
92 Pages
Global

From

€3500EUR$4,178USD£3,179GBP

Age-Related Macular Degeneration Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4029EUR$4,490USD£3,536GBP

Personalized Medicine Market Analysis & Forecast to 2024-2034

 Report
January 2024
200 Pages
Global

From

€3724EUR$4,150USD£3,268GBP

NEED HELP FINDING THE RIGHT PRODUCT? Hoseok will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Oligonucleotide Synthesis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

 Report
May 2025
182 Pages
Global

From

€4038EUR$4,500USD£3,544GBP

Antibody Drug Conjugates Market Report 2025

 Report
September 2025
250 Pages
Global

From

€4029EUR$4,490USD£3,536GBP

Multiple System Atrophy (MSA) - Market Insight, Epidemiology, and Market Forecast - 2034

 Report
January 2025
194 Pages
Global

From

€5707EUR$6,360USD£5,009GBP

€7134EUR$7,950USD£6,261GBP

Myeloproliferative Disorders Drugs Market Report 2025

 Report
September 2025
250 Pages
Global

From

€4029EUR$4,490USD£3,536GBP

Tumor Necrosis Factor Inhibitor Drugs Market Report 2025

 Report
September 2025
250 Pages
Global

From

€4029EUR$4,490USD£3,536GBP

Chemotherapy Market Report 2025

 Report
September 2025
250 Pages
Global

From

€4029EUR$4,490USD£3,536GBP

United States (US) Biotechnology Market Summary, Competitive Analysis and Forecast to 2028

 Report
February 2024
50 Pages
United States

From

€314EUR$350USD£276GBP

Precision Medicine - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
120 Pages
Global

From

€4262EUR$4,750USD£3,741GBP

The State of the Biopharmaceutical Industry 2025 (Mid-Year) Edition

 Report
June 2025
127 Pages
Global

From

€2647EUR$2,950USD£2,323GBP

Cell Therapy Technologies Market Report 2025

 Report
March 2025
200 Pages
Global

From

€4029EUR$4,490USD£3,536GBP

Cell and Gene Therapy Market Report 2025

 Report
March 2025
250 Pages
Global

From

€4029EUR$4,490USD£3,536GBP

Human Coagulation Factor VII Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
October 2024
93 Pages
Global

From

€3500EUR$4,178USD£3,179GBP

Human Coagulation Factor VIII Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2024
111 Pages
Global

From

€3500EUR$4,178USD£3,179GBP

Human Coagulation Factor IV Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2024
104 Pages
Global

From

€3500EUR$4,178USD£3,179GBP

Recombinant DNA Technology Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4029EUR$4,490USD£3,536GBP

860 Results (Page 35 of 43)
- 1
- 33
- 34
- 35
- 36
- 37

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.